Methotrexate Drugs Market, By Administration Route (Oral and Injection), By Sales Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Type of Treatment (Psoriasis, Rheumatoid Arthritis, and Cancer), By Region Analysis - Global Analysis And Industry Forecast Report Till 2030.

The Global Methotrexate Drugs Market is projected to grow from $0.57 billion to $0.75 billion, at a CAGR of 2.8% during the forecast period 2021-2030.

Methotrexate is a folic acid antagonist. Methotrexate is among the most effective and widely used drugs for treating inflammatory arthritis. It is also one of the safest arthritis treatments. A drug called Methotrexate is used to treat psoriasis and rheumatoid arthritis.

Methotrexate is also used to treat cancers that start in the tissue that forms around a fertilized egg. Some of the diseases in which it is used are the uterus, breast cancer, lung cancer, certain cancers of the head and neck, certain types of lymphoma, and leukemia (which start in cancerous white blood cells).

Cancer can be treated by slowing the growth of cancer cells, using Methotrexate. Methotrexate treats psoriasis by decreasing the speed of the growth of skin cells to prevent scales from forming. Rheumatoid arthritis can be treated by decreasing the activity of the immune system, using Methotrexate. Growth in the cases of the above-mentioned diseases is one of the major reasons which is propelling the market.

Market Dynamics:

Drivers:

An increasing number of drug approvals by regulatory agencies is expected to propel the growth of the global methotrexate drug market. For example, in 2022, NORDIC PHARMA, a SEVER Life Sciences company, published a report on severe, disabling active rheumatoid arthritis (RA) and symptoms of psoriasis that cause severe, intractable disability in adults who do not respond adequately to other forms of treatment control. Key market players are focusing on research and development of methotrexate drugs, which is expected to drive the global methotrexate drugs market during the forecast period.

Restraints:

Side effects associated with methotrexate drugs are expected to hamper the growth of the global methotrexate drugs market. Some side effects associated with the methotrexate drug include: Methotrexate can cause lung damage, methotrexate can damage the lining of the mouth, stomach, or intestines, methotrexate can reduce the activity of the immune system and many more reasons are likely to hinder the market growth.

Opportunities:

Factors such as awareness initiatives by organizations, the increasing prevalence of arthritis, and product launches are driving the methotrexate drug market growth globally. These initiatives by organizations and market participants are expected to boost the global methotrexate drug market growth during the forecast period. Additionally, there are several potential drugs in the pipeline for arthritis, and cancer, which are expected to spur the global methotrexate drug market growth and are anticipated to provide many opportunities in this market.

Key Players:

• LEO Pharma A/S

• Company Highlights

• Products Portfolio

• Key Highlights

• Financial Performance

• Strategies

• Bristol Myers Squibb

• Nordic Pharma

• Eli Lilly and Company

• Horizon Therapeutics plc.

• Cumberland Pharmaceuticals Inc.

• Azurity Pharmaceuticals, Inc.

• Pfizer Inc.

• Hikma Pharmaceuticals PLC.

• Onco Therapies Limited

Market Segmentation:

Methotrexate Drugs Market, By Type of Treatment

• Psoriasis

• Rheumatoid Arthritis

• Cancer

Methotrexate Drugs Market, By Administration Route

• Oral

• Injection

 Methotrexate Drugs Market, By Sales Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

 Methotrexate Drugs Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

North America holds the largest market share from geographic estimation, due to high healthcare expenditure and research and development. Many initiatives are taken by the organizations in this region which are likely to augment the growth of the market.

Asia-Pacific is expected to hold a position as the fastest-growing market share in the coming years for the methotrexate drugs market, owing to increasing technological advancements, rising healthcare spending, and increasing awareness programs.

Scope of the report:

User

Tab Content